LOC728545 Inhibitors
LOC728545 inhibitors encompass a variety of compounds that indirectly modulate the activity of this protein through intricate cellular signaling networks. By targeting key signaling nodes, these inhibitors can attenuate the functional activity of LOC728545. For instance, rapamycin's inhibition of mTOR disrupts the synthesis of proteins and the growth signals that may be necessary for LOC728545's stability or activity. MEK inhibitors like U0126 and PD98059 lead to the suppression of the ERK pathway, which, if LOC728545 is a downstream effector, would result in decreased activity of LOC728545. Similarly, AKT pathway inhibitors like LY294002, Wortmannin, and Triciribine could reduce LOC728545 activity if it relies on the AKT pathway for its activation or stability.
Proteasome inhibitors such as Bortezomib and MG132 might lead to the accumulation of proteins that can bind and inhibit the function or processing of LOC728545, thereby decreasing its activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin selectively inhibits mTOR (mammalian target of rapamycin), which is a crucial regulator of cell growth and proliferation. Inhibition of mTOR could lead to an overall reduction in cellular metabolism and protein synthesis, indirectly leading to the functional inhibition of LOC728545 if it relies on active cell growth signals. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. By broadly inhibiting kinase activity, staurosporine can dampen multiple signaling pathways, potentially including those that activate or stabilize LOC728545. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K (phosphoinositide 3-kinases). PI3K is involved in the AKT signaling pathway, which is important for cell survival and growth. Inhibiting PI3K would suppress AKT pathway activity, which could indirectly inhibit LOC728545 if its function is AKT-dependent. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase, which is involved in stress responses. Inhibiting p38 MAPK can disrupt cellular responses to stress, which might be necessary for the activation or function of LOC728545. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. Similar to LY294002, it would inhibit the PI3K/AKT pathway, possibly leading to decreased function of LOC728545 if it is PI3K/AKT-dependent. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK (c-Jun N-terminal kinase), which affects inflammatory responses and apoptosis. Inhibition of JNK could lead to the suppression of proteins regulated by this pathway, possibly including LOC728545. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor, similar to U0126, and would similarly inhibit the ERK pathway, potentially leading to the reduced activity of proteins regulated by ERK signaling, such as LOC728545. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the AKT signaling pathway, thereby reducing cell survival and proliferation signals that could indirectly inhibit LOC728545 if it is AKT-dependent. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, which could lead to the accumulation of misfolded proteins and induce cellular stress. This can disrupt normal protein function and turnover, potentially affecting the stability and function of LOC728545. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is another proteasome inhibitor, similar in function to Bortezomib. By inhibiting the proteasomal degradation pathway, it could indirectly affect the function of LOC728545 if it is subject to regulation by proteasomal degradation. | ||||||